{
    "patient": {
        "Name": "Sarah Jackson",
        "DateOfBirth": "1983-07-18",
        "Sex": "Female",
        "Diagnosis": "Medullary thyroid cancer",
        "BodyPart": "Thyroid",
        "Physician": "Dr. Stacy Rodriguez",
        "TreatingInstitution": "Dunlap PLC"
    },
    "specimen": {
        "Tumor specimen": {
            "source": "Thyroid",
            "CollectedDate": "2023-11-01",
            "ReceivedDate": "2023-11-01",
            "TumorPercentage": "96%"
        },
        "Normal specimen": {
            "source": "Blood",
            "CollectedDate": "2023-11-02",
            "ReceivedDate": "2023-11-03"
        }
    },
    "genomic variants": {
        "Somatic - Potentially Actionable": [
            {
                "Gene": "MUTYH",
                "DNA Alteration": "c.1014G>C",
                "GeneMutation": "p.Q338H Spliceregionvariant-GOF",
                "VariantAlleleFraction": "6.1%"
            },
            {
                "Gene": "ALK",
                "DNA Alteration": "c.3735C>A",
                "GeneMutation": "p.F1174V Spliceregionvariant-LOF",
                "VariantAlleleFraction": "5.34%"
            },
            {
                "Gene": "SRSF2",
                "DNA Alteration": "c.3113A>G",
                "GeneMutation": "p.P95X Frameshift-LOF",
                "VariantAlleleFraction": "21.07%"
            }
        ],
        "Somatic - Biologically Relevant": [
            {
                "Gene": "CSF1R",
                "DNA Alteration": "c.1085A>G",
                "GeneMutation": "p.N648S Missensevariant(exon2)-GOF",
                "VariantAlleleFraction": "3.81%"
            },
            {
                "Gene": "SDHA",
                "DNA Alteration": "c.1660C>T",
                "GeneMutation": "p.H362R Frameshift-LOF",
                "VariantAlleleFraction": "6.16%"
            }
        ],
        "Germline - Pathogenic": [],
        "Pertinent Negatives": []
    },
    "immunotherapy markers": [
        {
            "marker_name": "Tumor Mutational Burden",
            "TmbValue": "26 m/Mb",
            "Tmbpercentile": "38%",
            "Status type": "Microsatellite Instability Status",
            "statusvalue": "Stable"
        }
    ],
    "FDA-Approved Therapies": {
        "Current Diagnosis": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ],
        "Other Indications": [
            {
                "Mechanism": "KRAS G12C Inhibitors",
                "Medication": "Sotorasib",
                "Recommendations": [
                    "NCCN, Consensus, Non-Small Cell Lung Cancer",
                    "MSK OncoKB, Level 1"
                ],
                "Relevant Mutation": "KRASp.G12C G12C-GOF"
            }
        ]
    }
}